MGC pharma executes US$24M US supply agreement
Filed with ASX · · 5 pages · English
Earlier from Argent Biopharma
- Patent application lodged for novel drug delivery system
- 1St patient recruited into CimetrA phase 3 clinical trial
- CannEpil available for free dispensing in ireland
- MGC pharma 2021 clinical trials program update
- CimetrA patent submitted to European IP office
Later from Argent Biopharma
- Cimetra import approval granted for india
- UK import permit granted for CannEpil
- ArtemiC eu sale approval and clinical trial update
- First order received under US supply agreement
- AMC inc. places US$3M CimetrA purchase order
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma